Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 303

    1.

    Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.

    Nelson HD, Fu R, Griffin JC, Nygren P, Smith ME, Humphrey L.

    Ann Intern Med. 2009 Nov 17;151(10):703-15, W-226-35.PMID: 19920271 [PubMed - in process]Related articles

    2.

    Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data.

    von Heideman A, Berglund A, Larsson R, Nygren P.

    Cancer Chemother Pharmacol. 2009 Sep 30. [Epub ahead of print]PMID: 19789873 [PubMed - as supplied by publisher]Related articles

    3.

    Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cells.

    Laryea D, Gullbo J, Isaksson A, Larsson R, Nygren P.

    Anticancer Drugs. 2009 Sep 25. [Epub ahead of print]PMID: 19786863 [PubMed - as supplied by publisher]Related articles

    4.

    Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer.

    Nelson HD, Fu R, Griffin JC, Nygren P, Smith ME, Humphrey L.

    Ann Intern Med. 2009 Sep 14. [Epub ahead of print]PMID: 19755347 [PubMed - as supplied by publisher]Related articlesFree article

    5.

    Interactions of zoospores of Ulva linza with arginine-rich oligopeptide monolayers.

    Ederth T, Pettitt ME, Nygren P, Du CX, Ekblad T, Zhou Y, Falk M, Callow ME, Callow JA, Liedberg B.

    Langmuir. 2009 Aug 18;25(16):9375-83.PMID: 19719228 [PubMed - indexed for MEDLINE]Related articles

    6.

    Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.

    Löfdahl PA, Nord O, Janzon L, Nygren PA.

    N Biotechnol. 2009 Nov 30;26(5):251-9. Epub 2009 Jul 1.PMID: 19576305 [PubMed - in process]Related articles

    7.

    Affibody-mediated retention of the epidermal growth factor receptor in the secretory compartments leads to inhibition of phosphorylation in the kinase domain.

    Vernet E, Lundberg E, Friedman M, Rigamonti N, Klausing S, Nygren PA, Gräslund T.

    N Biotechnol. 2009 Sep;25(6):417-23.PMID: 19552886 [PubMed - indexed for MEDLINE]Related articles

    8.

    Transfer of nitrogen from a tropical legume tree to an associated fodder grass via root exudation and common mycelial networks.

    Jalonen R, Nygren P, Sierra J.

    Plant Cell Environ. 2009 Oct;32(10):1366-76. Epub 2009 Jun 10.PMID: 19552666 [PubMed - indexed for MEDLINE]Related articles

    9.

    Barriers and drivers of health information technology use for the elderly, chronically ill, and underserved.

    Jimison H, Gorman P, Woods S, Nygren P, Walker M, Norris S, Hersh W.

    Evid Rep Technol Assess (Full Rep). 2008 Nov;(175):1-1422. Review.PMID: 19408968 [PubMed - indexed for MEDLINE]Related articles

    10.

    An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer.

    Berglund A, Byström P, Johansson B, Nygren P, Frödin JE, Pedersen D, Letocha H, Glimelius B.

    Med Oncol. 2009 Feb 11. [Epub ahead of print]PMID: 19212708 [PubMed - as supplied by publisher]Related articles

    11.

    Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer.

    Byström P, Berglund A, Garske U, Jacobsson H, Sundin A, Nygren P, Frödin JE, Glimelius B.

    Ann Oncol. 2009 Jun;20(6):1057-61. Epub 2009 Jan 22.PMID: 19164458 [PubMed - indexed for MEDLINE]Related articles

    12.

    [If you are young you get it, but if you are old you are left out. The significance of age for choice of treatment and priorities in cancer care]

    Nygren P, Sandman L.

    Lakartidningen. 2008 Nov 19-25;105(47):3417-9. Swedish. No abstract available. PMID: 19112970 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rapamycin shows anticancer activity in primary chronic lymphocytic leukemia cells in vitro, as single agent and in drug combination.

    Aleskog A, Norberg M, Nygren P, Rickardson L, Kanduri M, Tobin G, Aberg M, Gustafsson MG, Rosenquist R, Lindhagen E.

    Leuk Lymphoma. 2008 Dec;49(12):2333-43.PMID: 19052982 [PubMed - indexed for MEDLINE]Related articles

    14.

    In vitro activity of bortezomib in cultures of patient tumour cells--potential utility in haematological malignancies.

    Wiberg K, Carlson K, Aleskog A, Larsson R, Nygren P, Lindhagen E.

    Med Oncol. 2009;26(2):193-201. Epub 2008 Nov 18.PMID: 19016012 [PubMed - indexed for MEDLINE]Related articles

    15.

    Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients.

    Laryea D, Isaksson A, Wright CW, Larsson R, Nygren P.

    Invest New Drugs. 2009 Oct;27(5):402-11. Epub 2008 Oct 14.PMID: 18853102 [PubMed - indexed for MEDLINE]Related articles

    16.

    The fluorometric microculture cytotoxicity assay.

    Lindhagen E, Nygren P, Larsson R.

    Nat Protoc. 2008;3(8):1364-9.PMID: 18714304 [PubMed - indexed for MEDLINE]Related articles

    17.

    Affinity-based entrapment of the HER2 receptor in the endoplasmic reticulum using an affibody molecule.

    Vernet E, Konrad A, Lundberg E, Nygren PA, Gräslund T.

    J Immunol Methods. 2008 Sep 30;338(1-2):1-6. Epub 2008 Jul 29.PMID: 18671978 [PubMed - indexed for MEDLINE]Related articles

    18.

    Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia.

    Lindhagen E, Eriksson A, Wickström M, Danielsson K, Grundmark B, Henriksson R, Nygren P, Aleskog A, Larsson R, Höglund M.

    Eur J Haematol. 2008 Nov;81(5):344-53. Epub 2008 Jul 10.PMID: 18637032 [PubMed - indexed for MEDLINE]Related articles

    19.

    Anomalous settlement behavior of Ulva linza zoospores on cationic oligopeptide surfaces.

    Ederth T, Nygren P, Pettitt ME, Ostblom M, Du CX, Broo K, Callow ME, Callow J, Liedberg B.

    Biofouling. 2008 Jun 6:303-312. [Epub ahead of print]PMID: 18608183 [PubMed - as supplied by publisher]Related articles

    20.

    Universal newborn hearing screening: systematic review to update the 2001 US Preventive Services Task Force Recommendation.

    Nelson HD, Bougatsos C, Nygren P; 2001 US Preventive Services Task Force.

    Pediatrics. 2008 Jul;122(1):e266-76. Review. Erratum in: Pediatrics. 2008 Sep;122(3):689. PMID: 18595973 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Anomalous settlement behavior of Ulva linza zoospores on cationic oligopeptide surfaces.

    Ederth T, Nygren P, Pettitt ME, Ostblom M, Du CX, Broo K, Callow ME, Callow J, Liedberg B.

    Biofouling. 2008;24(4):303-12.PMID: 18589494 [PubMed - indexed for MEDLINE]Related articles

    22.

    Fundamental design principles that guide induction of helix upon formation of stable peptide-nanoparticle complexes.

    Nygren P, Lundqvist M, Broo K, Jonsson BH.

    Nano Lett. 2008 Jul;8(7):1844-52. Epub 2008 Jun 10.PMID: 18540660 [PubMed - indexed for MEDLINE]Related articles

    23.

    Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy.

    Hansson J, Graf W, Påhlman L, Nygren P, Mahteme H.

    Eur J Surg Oncol. 2009 Feb;35(2):202-8. Epub 2008 Jun 2.PMID: 18514475 [PubMed - indexed for MEDLINE]Related articles

    24.

    Immobilized chemoattractant peptides mediate adhesion and distinct calcium-dependent cell signaling in human neutrophils.

    Wetterö J, Hellerstedt T, Nygren P, Broo K, Aili D, Liedberg B, Magnusson KE.

    Langmuir. 2008 Jun 1;24(13):6803-11. Epub 2008 May 29.PMID: 18507416 [PubMed - indexed for MEDLINE]Related articles

    25.

    Engineering of a femtomolar affinity binding protein to human serum albumin.

    Jonsson A, Dogan J, Herne N, Abrahmsén L, Nygren PA.

    Protein Eng Des Sel. 2008 Aug;21(8):515-27. Epub 2008 May 22.PMID: 18499681 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.

    Nygren PA.

    FEBS J. 2008 Jun;275(11):2668-76. Epub 2008 Apr 24. Review.PMID: 18435759 [PubMed - indexed for MEDLINE]Related articles

    27.

    Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force.

    Nygren P, Fu R, Freeman M, Bougatsos C, Klebanoff M, Guise JM; U.S. Preventive Services Task Force.

    Ann Intern Med. 2008 Feb 5;148(3):220-33. Review.PMID: 18252684 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Radiological assessment of tumour response to anti-cancer drugs: time to reappraise.

    Nygren P, Blomqvist L, Bergh J, Aström G.

    Acta Oncol. 2008;47(2):316-8. No abstract available. PMID: 18210304 [PubMed - indexed for MEDLINE]Related articles

    29.

    Applying a universal scaling model to vascular allometry in a single-stemmed, monopodially branching deciduous tree (Attim's model).

    Nygren P, Pallardy SG.

    Tree Physiol. 2008 Jan;28(1):1-10.PMID: 17938108 [PubMed - indexed for MEDLINE]Related articles

    30.

    The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro.

    Wickström M, Haglund C, Lindman H, Nygren P, Larsson R, Gullbo J.

    Invest New Drugs. 2008 Jun;26(3):195-204. Epub 2007 Oct 6.PMID: 17922077 [PubMed - indexed for MEDLINE]Related articles

    31.

    Modeling of in vitro drug activity and prediction of clinical outcome in acute myeloid leukemia.

    Quartino A, Karlsson MO, Freijs A, Jonsson N, Nygren P, Kristensen J, Lindhagen E, Larsson R.

    J Clin Pharmacol. 2007 Aug;47(8):1014-21.PMID: 17660484 [PubMed - indexed for MEDLINE]Related articles

    32.

    The pharmacist and quality of cancer chemotherapy.

    Nygren P.

    Acta Oncol. 2007;46(6):715-6. No abstract available. PMID: 17653891 [PubMed - indexed for MEDLINE]Related articles

    33.

    Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis.

    Mahteme H, von Heideman A, Grundmark B, Tholander B, Påhlman L, Glimelius B, Larsson R, Graf W, Nygren P.

    Eur J Surg Oncol. 2008 May;34(5):547-52. Epub 2007 Jun 18.PMID: 17574369 [PubMed - indexed for MEDLINE]Related articles

    34.

    Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer.

    Lindman H, Aström G, Ahlgren J, Villman K, Blomqvist C, Nygren P, Bergh J.

    Acta Oncol. 2007;46(2):165-71.PMID: 17453364 [PubMed - indexed for MEDLINE]Related articles

    35.

    Consequences of membrane protein overexpression in Escherichia coli.

    Wagner S, Baars L, Ytterberg AJ, Klussmeier A, Wagner CS, Nord O, Nygren PA, van Wijk KJ, de Gier JW.

    Mol Cell Proteomics. 2007 Sep;6(9):1527-50. Epub 2007 Apr 19.PMID: 17446557 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro.

    Lindhagen E, Rickardson L, Elliott G, Leoni L, Nygren P, Larsson R, Aleskog A.

    Invest New Drugs. 2007 Aug;25(4):297-303. Epub 2007 Apr 18.PMID: 17440681 [PubMed - indexed for MEDLINE]Related articles

    37.

    Combinatorial expression vector engineering for tuning of recombinant protein production in Escherichia coli.

    Bandmann N, Nygren PA.

    Nucleic Acids Res. 2007;35(5):e32. Epub 2007 Jan 30.PMID: 17264122 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Affibody molecules in protein capture microarrays: evaluation of multidomain ligands and different detection formats.

    Renberg B, Nordin J, Merca A, Uhlén M, Feldwisch J, Nygren PA, Karlström AE.

    J Proteome Res. 2007 Jan;6(1):171-9.PMID: 17203961 [PubMed - indexed for MEDLINE]Related articles

    39.

    ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome.

    Taussig MJ, Stoevesandt O, Borrebaeck CA, Bradbury AR, Cahill D, Cambillau C, de Daruvar A, Dübel S, Eichler J, Frank R, Gibson TJ, Gloriam D, Gold L, Herberg FW, Hermjakob H, Hoheisel JD, Joos TO, Kallioniemi O, Koegl M, Konthur Z, Korn B, Kremmer E, Krobitsch S, Landegren U, van der Maarel S, McCafferty J, Muyldermans S, Nygren PA, Palcy S, Plückthun A, Polic B, Przybylski M, Saviranta P, Sawyer A, Sherman DJ, Skerra A, Templin M, Ueffing M, Uhlén M.

    Nat Methods. 2007 Jan;4(1):13-7. Erratum in: Nat Methods. 2007 Feb;4(2):187. Koegll, Manfred [corrected to Koegl, Manfred]. PMID: 17195019 [PubMed - indexed for MEDLINE]Related articles

    40.

    Screening for elevated lead levels in childhood and pregnancy: an updated summary of evidence for the US Preventive Services Task Force.

    Rischitelli G, Nygren P, Bougatsos C, Freeman M, Helfand M.

    Pediatrics. 2006 Dec;118(6):e1867-95. Review.PMID: 17142507 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Induction of structure and function in a designed peptide upon adsorption on a silica nanoparticle.

    Lundqvist M, Nygren P, Jonsson BH, Broo K.

    Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8169-73. No abstract available. PMID: 17121400 [PubMed - indexed for MEDLINE]Related articles

    42.

    STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines.

    Fryknäs M, Dhar S, Oberg F, Rickardson L, Rydåker M, Göransson H, Gustafsson M, Pettersson U, Nygren P, Larsson R, Isaksson A.

    Int J Cancer. 2007 Jan 1;120(1):189-95.PMID: 17072862 [PubMed - indexed for MEDLINE]Related articles

    43.

    Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.

    Myhre S, Henning P, Granio O, Tylö AS, Nygren PA, Olofsson S, Boulanger P, Lindholm L, Hong SS.

    Gene Ther. 2007 Feb;14(4):376-81. Epub 2006 Oct 12.PMID: 17036056 [PubMed - indexed for MEDLINE]Related articles

    44.

    Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients.

    Wickström M, Danielsson K, Rickardson L, Gullbo J, Nygren P, Isaksson A, Larsson R, Lövborg H.

    Biochem Pharmacol. 2007 Jan 1;73(1):25-33. Epub 2006 Aug 26.PMID: 17026967 [PubMed - indexed for MEDLINE]Related articles

    45.

    Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.

    Fryknäs M, Rickardson L, Wickström M, Dhar S, Lövborg H, Gullbo J, Nygren P, Gustafsson MG, Isaksson A, Larsson R.

    J Biomol Screen. 2006 Aug;11(5):457-68.PMID: 16928983 [PubMed - indexed for MEDLINE]Related articles

    46.

    Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review.

    Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD.

    Arch Intern Med. 2006 Jul 24;166(14):1453-65. Review.PMID: 16864755 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Telomerase activity is not a key determinant of sensitivity to standard cytotoxic drugs in human esophageal carcinoma cell lines.

    Dreilich M, Lindkvist A, Dhar S, Paulsson-Karlsson Y, Brattström D, Nygren P, Rickardson L, Wagenius G, Bergqvist M.

    Anticancer Drugs. 2006 Jun;17(5):503-9.PMID: 16702806 [PubMed - indexed for MEDLINE]Related articles

    48.

    Physicians, patients, and the electronic health record: an ethnographic analysis.

    Ventres W, Kooienga S, Vuckovic N, Marlin R, Nygren P, Stewart V.

    Ann Fam Med. 2006 Mar-Apr;4(2):124-31.PMID: 16569715 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Screening of an annotated compound library for drug activity in a resistant myeloma cell line.

    Rickardson L, Fryknäs M, Haglund C, Lövborg H, Nygren P, Gustafsson MG, Isaksson A, Larsson R.

    Cancer Chemother Pharmacol. 2006 Dec;58(6):749-58. Epub 2006 Mar 10.PMID: 16528529 [PubMed - indexed for MEDLINE]Related articles

    50.

    Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients.

    Sandström M, Lindman H, Nygren P, Johansson M, Bergh J, Karlsson MO.

    Cancer Chemother Pharmacol. 2006 Aug;58(2):143-56. Epub 2006 Feb 8.PMID: 16465545 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...